P

Inventor

HOWARD STEVEN

US54 patents
⚠️ This page may combine multiple inventors who share the name “HOWARD STEVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ASTEX THERAPEUTICS LTD

20 patents
US7977477B2Jul 12, 2011

Benzimidazole derivatives and their use as protein kinase inhibitors

ASTEX THERAPEUTICS LTD35 citations92
US9783538B2Oct 10, 2017

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD12 citations91
US9458158B2Oct 4, 2016

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD11 citations84
US10618895B2Apr 14, 2020

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD4 citations83
US9676768B2Jun 13, 2017

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD8 citations83
US9617248B2Apr 11, 2017

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD10 citations83
US9617283B2Apr 11, 2017

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD10 citations83
US10544132B2Jan 28, 2020

Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

ASTEX THERAPEUTICS LTD10 citations82
US10526311B2Jan 7, 2020

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

ASTEX THERAPEUTICS LTD6 citations82
US9663512B2May 30, 2017

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD8 citations82
US11866428B2Jan 9, 2024

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD2 citations72
US11643410B2May 9, 2023

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD1 citations72
US11225476B2Jan 18, 2022

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD3 citations72
US11261171B1Mar 1, 2022

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

ASTEX THERAPEUTICS LTD2 citations71
US10981898B2Apr 20, 2021

Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

ASTEX THERAPEUTICS LTD4 citations71
US9980973B2May 29, 2018

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD6 citations71
US11603367B2Mar 14, 2023

Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

ASTEX THERAPEUTICS LTD2 citations66
US12202828B2Jan 21, 2025

Bicyclic heterocycle compounds and their uses in therapy

ASTEX THERAPEUTICS LTD0 citations62
US12071429B2Aug 27, 2024

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

ASTEX THERAPEUTICS LTD0 citations60
US12077526B2Sep 3, 2024

Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

ASTEX THERAPEUTICS LTD1 citations54

CROSS VASCULAR INC

4 patents

OTSUKA PHARMA CO LTD

4 patents

RETRACTORTHO INC

4 patents

BERDINI VALERIO

2 patents

AADVANCE TECH LLC

2 patents

HOWARD STEVEN

2 patents

SMITHKLINE BEECHAM PLC

2 patents

BLAIN JASON

1 patent

SPINAL ELEMENTS INC

1 patent

BESONG GILBERT EBAI

1 patent

LSI LOGIC CORP

1 patent

BUCK ILDIKO MARIA

1 patent

WOOLFORD ALISON JO-ANNE

1 patent

BESONG GILBERT

1 patent

TAIHO PHARMACEUTICAL CO LTD

1 patent

QUALCOMM INC

1 patent

FREEDMAN ELECTRONICS PTY LTD

1 patent

Showing the top 50 of 54 patents by PatentIndex Score.